International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released Aug 13, 2026, after the close
10-Q filed Aug 13, 2026, 44 days after period end · 0001193125-26-349108
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $2.68M | $2.45M | $2.33M | $1.84M |
| Net Income | -$71.00K | $129.00K | $119.00K | $492.00K |
| EPS Diluted | -$0.01 |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| $0.01 |
| $0.01 |
| $0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
